Market News & Trends
Blend Therapeutics Secures $21 Million and Unveils Novel Pentarin Platform
Blend Therapeutics, Inc. recently announced it has secured $21 million in new funding. The new financing includes additional equity investment from a new investor and…
Amgen & Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration
Amgen (NASDAQ:AMGN) and Kite Pharma (NASDAQ:KITE) recently announced the two companies have entered into a strategic research collaboration and license agreement to develop and commercialize…
Incyte & Agenus Announce Global Alliance to Develop Novel Immuno-Oncology Antibodies
Incyte Corporation and Agenus Inc. recently announced a global license, development, and commercialization agreement focused on novel immuno-therapeutics using Agenus’ proprietary Retrocyte Display antibody discovery…
Capsugel Acquires Ionic Liquids Technology
Morristown, N.J., and Melbourne, Australia – Capsugel and Monash University recently announced that Capsugel has acquired the intellectual property pertaining to proprietary Ionic Liquids Technology…
Moderna Launches New Venture for Infectious Diseases
Moderna Therapeutics recently announced the launch of Valera LLC, a new Moderna venture focused exclusively on the advancement of vaccines and therapeutics for the prevention…
Surface Oncology Announces $35-Million Financing to Advance Next-Generation Cancer Immunotherapies
Surface Oncology recently announced it has closed a $35-million Series A investment round led by Atlas Venture, which initially seeded the company in 2014, Fidelity…
Lyophilization Services of New England Receives Approval to Manufacture Commercial Aseptic Product
Lyophilization Services of New England, Inc. (LSNE) recently announced that following an FDA Pre-Approval Inspection (PAI) in November 2014, their Harvey Road manufacturing site has…
Record Number of Medicines for Rare Diseases Recommended for Approval in 2014
In 2014, the European Medicines Agency (EMA) recommended the highest number of orphan designated medicines for marketing authorisation in a year. Out of the 82…
Recently Discovered Super-Antibiotic Hailed as a Game-Changer
By: Anna Azvolinsky | January 7, 2015 | The Scientist Many of the most widely used antibiotics have come out of the dirt. Penicillin…
Roche to Acquire Dutalys to Augment Development Pipeline
Roche recently announced it has agreed to acquire Dutalys GmbH, which specializes in the discovery and development of fully human, bi-specific antibodies based on its…
Phylogica Enters Research & Licensing Agreement With Genentech
Phylogica Ltd. recently announced it has extended its collaboration with Genentech, a member of the Roche Group, by entering into a Research and Licensing agreement…
Achillion Shows Potential for Best-in-Disease Regimen
Achillion Pharmaceuticals, Inc. recently announced positive interim results from two studies supporting a short duration, potentially best-in-disease regimen of its proprietary NS5A and nucleotide inhibitors,…
ARIAD & Otsuka Announce Co-Development & Commercialization Agreement
ARIAD Pharmaceuticals, Inc. and Otsuka Pharmaceutical Co., Ltd. recently announced they have entered into an agreement for Otsuka to commercialize ARIAD’s Iclusig (ponatinib) in Japan…
Actavis Confirms Receipt of Complete Response Letter
Actavis plc recently confirmed it has received a complete response letter from the US FDA for its New Drug Application (NDA) for the fixed-dose combination…
Gilead Announces Amended Agreements With Janssen
Gilead Sciences, Inc. recently announced an expansion to its agreement with Janssen R&D Ireland for the development and commercialization of a new once-daily single tablet…
Roche to Enter the Genomic Informatics Market
Roche recently announced the acquisition of Bina Technologies, Inc. (Bina), a privately held company based in Redwood City, California, USA. Bina provides a big data…
FUJIFILM Completes Acquisition of Biotherapeutics Company
FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a FUJIFILM Corporation subsidiary, recently announced the completion of its acquisition of Kalon Biotherapeutics LLC, marking an important new chapter…
Top 30 Pharma Companies Spent $112 Billion on Research & Development in 2013
LONDON, UK (GlobalData), 16 December 2014 - The world’s leading 30 pharmaceutical companies spent a combined $112 billion on research and development (R&D) in 2013,…
Insys Therapeutics Receives FDA Orphan Drug Designation
Insys Therapeutics, Inc. recently announced that the US FDA has granted orphan drug designation (ODD) to its Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) candidate…
Unilife Signs Long-Term Commercial Supply Agreement for Use of Depot-jectTM Delivery System
Unilife Corporation recently announced the signing of a worldwide 10-year Commercial Supply Agreement with a global pharmaceutical company for the use of the Depot-jectTM delivery…
